On the other hand, pathogenic variants in EPHB4 explain the phenotype seen in CM-AVM2 syndrome, which is associated with various skin manifestations such as telangiectasias and angiospastic macules, epistaxis, and penetrance reported around 93% [5, 13, 15]. This evidence concerns the gene EPHB4 and telangiectasis.